Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Genelabs Technologies describes hepatitis E virus

June 21, 1996

Alpha1-adrenoceptor antagonists described

June 21, 1996

E. Merck reports fibrinogen (gpIIb/IIIa) antagonists

June 21, 1996

Modified factor VII described for coagulation-related disorders

June 21, 1996

ST-899 and ST-776 claimed by Sigma-Tau

June 21, 1996

TFPI as tissue injury inhibitor

June 21, 1996

Pierre Fabre reveals cardiac cytoprotective agents

June 21, 1996

Roussel Uclaf discloses endothelin antagonists

June 21, 1996

Endothelin antagonist claimed by Roche

June 21, 1996

Thymosin beta4 as cystic fibrosis treatment

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...